Re: Muayad et al.: Comparative effects of glucagon-like peptide 1 receptor agonists and metformin on glaucoma risk in patients with type 2 diabetes (Ophthalmology. 2025;132:271-279).
Ophthalmology
論文與作者
Ophthalmology. 2025;132(4):e61.
Wei-Hsuan Bai; Yi-Chiao Bai; James Cheng-Chung Wei